Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1680
    +0.0024 (+0.20%)
     
  • GBP/USD

    1.2492
    -0.0019 (-0.15%)
     
  • Bitcoin GBP

    51,249.74
    -547.39 (-1.06%)
     
  • CMC Crypto 200

    1,330.16
    -66.37 (-4.58%)
     
  • S&P 500

    5,111.72
    +63.30 (+1.25%)
     
  • DOW

    38,317.58
    +231.78 (+0.61%)
     
  • CRUDE OIL

    83.94
    +0.37 (+0.44%)
     
  • GOLD FUTURES

    2,350.20
    +7.70 (+0.33%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Is Now The Time To Look At Buying Marlowe plc (LON:MRL)?

Marlowe plc (LON:MRL), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the AIM over the last few months, increasing to UK£8.96 at one point, and dropping to the lows of UK£7.44. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Marlowe's current trading price of UK£8.05 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Marlowe’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for Marlowe

What's the opportunity in Marlowe?

According to my valuation model, Marlowe seems to be fairly priced at around 5.1% below my intrinsic value, which means if you buy Marlowe today, you’d be paying a reasonable price for it. And if you believe the company’s true value is £8.48, then there’s not much of an upside to gain from mispricing. So, is there another chance to buy low in the future? Given that Marlowe’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility.

Can we expect growth from Marlowe?

earnings-and-revenue-growth
earnings-and-revenue-growth

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. In Marlowe's case, its revenues over the next few years are expected to grow by 66%, indicating a highly optimistic future ahead. If expense does not increase by the same rate, or higher, this top line growth should lead to stronger cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? It seems like the market has already priced in MRL’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping tabs on MRL, now may not be the most optimal time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. Case in point: We've spotted 1 warning sign for Marlowe you should be aware of.

If you are no longer interested in Marlowe, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.